Want to see AU:PIQ full AI Analyst Report?
Total Valuation
Proteomics International Laboratories Ltd. has a market cap or net worth of AU$20.67M. The enterprise value is AU$99.81.
Market CapAU$20.67M
Enterprise ValueAU$99.81
Share Statistics
Proteomics International Laboratories Ltd. has 165,373,120 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding165,373,120
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Proteomics International Laboratories Ltd.’s return on equity (ROE) is -1.47 and return on invested capital (ROIC) is -132.04%.
Return on Equity (ROE)-1.47
Return on Assets (ROA)-0.96
Return on Invested Capital (ROIC)-132.04%
Return on Capital Employed (ROCE)-1.70
Revenue Per Employee1.73K
Profits Per Employee-53.17K
Employee Count161
Asset Turnover0.03
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Proteomics International Laboratories Ltd. is ―. Proteomics International Laboratories Ltd.’s PEG ratio is 0.54.
PE Ratio―
PS Ratio67.98
PB Ratio3.26
Price to Fair Value3.26
Price to FCF-2.40
Price to Operating Cash Flow-2.41
PEG Ratio0.54
Income Statement
In the last 12 months, Proteomics International Laboratories Ltd. had revenue of 278.01K and earned -8.56M in profits. Earnings per share was -0.05.
Revenue278.01K
Gross Profit-9.07M
Operating Income-11.89M
Pretax Income-10.78M
Net Income-8.56M
EBITDA-11.08M
Earnings Per Share (EPS)-0.05
Cash Flow
In the last 12 months, operating cash flow was -5.87M and capital expenditures -2.01M, giving a free cash flow of -7.88M billion.
Operating Cash Flow-5.87M
Free Cash Flow-7.88M
Free Cash Flow per Share-0.05
Dividends & Yields
Proteomics International Laboratories Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.36
52-Week Price Change-60.29%
50-Day Moving Average0.15
200-Day Moving Average0.28
Relative Strength Index (RSI)51.17
Average Volume (3m)91.31K
Important Dates
Proteomics International Laboratories Ltd. upcoming earnings date is Feb 25, 2027, TBA (Confirmed).
Last Earnings DateAug 31, 2026
Next Earnings DateFeb 25, 2027
Ex-Dividend Date―
Financial Position
Proteomics International Laboratories Ltd. as a current ratio of 3.19, with Debt / Equity ratio of 5.70%
Current Ratio3.19
Quick Ratio3.19
Debt to Market Cap0.01
Net Debt to EBITDA0.29
Interest Coverage Ratio-288.41
Taxes
In the past 12 months, Proteomics International Laboratories Ltd. has paid -2.17M in taxes.
Income Tax-2.17M
Effective Tax Rate0.20
Enterprise Valuation
Proteomics International Laboratories Ltd. EV to EBITDA ratio is -1.42, with an EV/FCF ratio of -2.00.
EV to Sales56.59
EV to EBITDA-1.42
EV to Free Cash Flow-2.00
EV to Operating Cash Flow-2.68
Balance Sheet
Proteomics International Laboratories Ltd. has AU$3.50M in cash and marketable securities with AU$331.13K in debt, giving a net cash position of AU$3.17M billion.
Cash & Marketable SecuritiesAU$3.50M
Total DebtAU$331.13K
Net CashAU$3.17M
Net Cash Per ShareAU$0.02
Tangible Book Value Per ShareAU$0.03
Margins
Gross margin is -3262.02%, with operating margin of -4275.74%, and net profit margin of -3078.86%.
Gross Margin-3262.02%
Operating Margin-4275.74%
Pretax Margin-3878.38%
Net Profit Margin-3078.86%
EBITDA Margin-3984.42%
EBIT Margin-4275.74%
Analyst Forecast
The average price target for Proteomics International Laboratories Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-23.71%
EPS Growth Forecast-16.02%